Cardio Diagnostics Holdings, Inc. (NASDAQ:CDIOW) Sees Significant Decline in Short Interest

Cardio Diagnostics Holdings, Inc. (NASDAQ:CDIOW) saw a large decrease in short interest in November. As of November 15th, there was short interest totalling 15,400 shares, a decrease of 32.5% from the October 31st total of 22,800 shares. Based on an average trading volume of 6,300 shares, the short-interest ratio is presently 2.4 days.

Cardio Diagnostics Price Performance

Shares of NASDAQ:CDIOW traded down $0.01 during midday trading on Friday, hitting $0.03. The company had a trading volume of 157 shares, compared to its average volume of 14,558. Cardio Diagnostics has a twelve month low of $0.02 and a twelve month high of $0.28. The business’s 50-day simple moving average is $0.03 and its 200-day simple moving average is $0.04.

Cardio Diagnostics Company Profile

Cardio Diagnostics Holdings, Inc develops and commercializes epigenetics-based clinical tests for cardiovascular disease. It offers Epi+Gen CHD, a three-year symptomatic coronary heart disease (CHD) risk assessment test targeting CHD events, including heart attacks; and PrecisionCHD, an integrated epigenetic-genetic blood test for the early detection of coronary heart disease.